Showing 1 posts of 1 posts found.
As far as months go, March 2016 couldn’t have gone much worse for Valeant Pharmaceuticals. The Canada-based company has been …
Stryker invests US$400m in CMR Surgical and secures option to acquire business
AI: an early warning system for patient safety
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
Highlighting the value of lab research for healthcare innovation
Capital Dynamics invests €14m in Italian community healthcare platform CareHub